Criminal Poisoning: Drug-Facilitated Sexual Assault

Emergency Medicine Clinics of North America

Volumn 25, Issue 2, 2007, Pages 499-525

  Bechtel, Laura K ^a   Holstege, Christopher P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BUTANEDIOL; 4 HYDROXYBUTYRIC ACID; ALCOHOL; ANTIHISTAMINIC AGENT; ATROPINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CHLORPHENIRAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DEXTROMETHORPHAN; DIAZEPAM; DIPHENHYDRAMINE; ESZOPICLONE; FEXOFENADINE; FLUNITRAZEPAM; GAMMA BUTYROLACTONE; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; KETAMINE; OPIATE DERIVATIVE; SCOPOLAMINE; TEMAZEPAM; TETRAZEPAM; TRIAZOLAM; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ALCOHOL ABUSE; ALCOHOL INTOXICATION; ANTEROGRADE AMNESIA; BLOOD ANALYSIS; CLINICAL ASSESSMENT; DRUG CLASSIFICATION; DRUG DETERMINATION; DRUG INTOXICATION; EMERGENCY CARE; FORENSIC IDENTIFICATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPNOSIS; LAW; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SEDATION; SEXUAL CRIME; URINALYSIS;

EID: 34247586693     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2007.02.008     Document Type: Review

References (118)

1. Anonymous. ACOG issues report on sexual assault - American College of Obstetricians and Gynecologists - special medical reports. American Family Physician March 1, 1998.
2. Rose V.L. National Criminal Victimization Survey, 2003 (2004), Bureau of Justice Statistics: U.S. Department of Justice
3. Kilpatrick D.G., Edmonds C.N., and Seymour A. Rape in America: a report to the Nation (1992), National Center for Victims of Crime and Crime Victims Research and Treatment Center, Arlington (VA)
4. Fisher B.S., Cullen F.T., and Turner M.G. The sexual victimization of college women (2000), Department of Justice (US), National Institute of Justice, Washington, DC NCJ 182369
5. Grunbaum J.A., Kann L., Kinchen S., et al. Youth risk behavior surveillance-United States, 2003. MMWR Surveill Summ 53 2 (2004) 1-96
6. Tjaden P., and Thoennes N. Full report of the prevalence, incidence, and consequences of violence against women: findings from the National Violence Against Women Survey (2000), National Institute of Justice, Washington, DC NCJ 183781
7. ElSohly M.A., and Salamone S.J. Prevalence of drugs used in cases of alleged sexual assault. J Anal Toxicol 23 3 (1999) 141-146
8. Hindmarch I., ElSohly M., Gambles J., et al. Forensic urinalysis of drug use in cases of alleged sexual assault. J Clin Forensic Med 8 4 (2001) 197-205
9. Slaughter L. Involvement of drugs in sexual assault. J Reprod Med 45 5 (2000) 425-430
10. Negrusz A., Juhascik M., and Gaensslen R.E. Estimate of the incidence of drug-facilitated sexual assault in the U.S (2005), U.S. Department of Justice
11. Fitzgerald N, Riley KJ. Drug-facilitated rape: looking for the missing pieces. National Institute of Justice Journal 2000;243:8-15.
12. Anonymous. Personal crimes of violence. In: US Justice Department of Justice- Bureau of Justice Statistics Criminal Victimization in the United States; 2004.
13. Marc B., Baudry F., Vaquero P., et al. Sexual assault under benzodiazepine submission in a Paris suburb. Arch Gynecol Obstet 263 4 (2000) 193-197
14. McGregor M.J., Lipowska M., Shah S., et al. An exploratory analysis of suspected drug-facilitated sexual assault seen in a hospital emergency department. Women Health 37 3 (2003) 71-80
15. McGregor M.J., Du Mont J., and Myhr T.L. Sexual assault forensic medical examination: is evidence related to successful prosecution?. Ann Emerg Med 39 6 (2002) 639-647
16. Campbell R. Rape survivors' experiences with the legal and medical systems: do rape victim advocates make a difference?. Violence Against Women 12 1 (2006) 30-45
17. Burgess A.W., Fehder W.P., and Hartman C.R. Delayed reporting of the rape victim. J Psychosoc Nurs Ment Health Serv 33 9 (1995) 21-29
18. Plumbo M.A. Delayed reporting of sexual assault. Implications for counseling. J Nurse Midwifery 40 5 (1995) 424-427
19. Adamowicz P., and Kala M. Date-rape drugs scene in Poland. Przegl Lek 62 6 (2005) 572-575 [in Polish]
20. Goulle J.P., and Anger J.P. Drug-facilitated robbery or sexual assault: problems associated with amnesia. Ther Drug Monit 26 2 (2004) 206-210
21. Scott-Ham M., and Burton F.C. Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period. J Clin Forensic Med 12 4 (2005) 175-186
22. Rennison C. Rape and sexual assault: reporting to police and medical attention, 1992-2000. In: Rand MaG L. (Ed) (2002), U.S. Department of Justice, Washington, DC 1-4
23. Cybulska B., and Forster G. Sexual assault: examination of the victim. Medicine 33 9 (2005) 23-28
24. Feldhaus K.M., Houry D., and Kaminsky R. Lifetime sexual assault prevalence rates and reporting practices in an emergency department population. Ann Emerg Med 36 1 (2000) 23-27
25. Anonymous. A National protocol for sexual assault medical forensic examinations: adults/adolescents. Office for violence against women (2004), US Department of Justice NCJ 206554
26. Kintz P., Villain M., and Cirimele V. Hair analysis for drug detection. Ther Drug Monit 28 3 (2006) 442-446
27. Cone E.J. Legal, workplace, and treatment drug testing with alternate biological matrices on a global scale. Forensic Sci Int 121 (2001) 7-15
28. Negrusz A., and Gaensslen R.E. Analytical developments in toxicological investigation of drug-facilitated sexual assault. Anal Bioanal Chem 376 8 (2003) 1192-1197
29. Negrusz A., Moore C.M., Kern J.L., et al. Quantitation of clonazepam and its major metabolite 7-aminoclonazepam in hair. J Anal Toxicol 24 7 (2000) 614-620
30. Kintz P., Villain M., and Ludes B. Testing for the undetectable in drug-facilitated sexual assault using hair analyzed by tandem mass spectrometry as evidence. Ther Drug Monit 26 2 (2004) 211-214
31. Anonymous. Percent distribution of victimizations by perceived drug or alcohol use by offender. Table 32 (2004), Personal crimes of violence
32. Dyer J., and Kim S.Y. Drug facilitated sexual assault: a review of 24 incidents. [abstract]. J Toxicol Clin Toxicol 42 4 (2004) 519
33. Abbey A., Zawacki T., Buck P.O., et al. How does alcohol contribute to sexual assault? Explanations from laboratory and survey data. Alcohol Clin Exp Res 26 4 (2002) 575-581
34. Murdoch D., Pihl R.O., and Ross D. Alcohol and crimes of violence: present issues. Int J Addict 25 9 (1990) 1065-1081
35. Ledray L.E. The clinical care and documentation for victims of drug-facilitated sexual assault. J Emerg Nurs 27 3 (2001) 301-305
36. LeBeau M., Andollo W., Hearn W.L., et al. Recommendations for toxicological investigations of drug-facilitated sexual assaults. J Forensic Sci 44 1 (1999) 227-230
37. Mohler-Kuo M., Dowdall G.W., Koss M.P., et al. Correlates of rape while intoxicated in a national sample of college women. J Stud Alcohol 65 1 (2004) 37-45
38. Cole T.B. Rape at US colleges often fueled by alcohol. JAMA 296 5 (2006) 504-505
39. Holford N.H. Clinical pharmacokinetics of ethanol. Clin Pharmacokinet 13 5 (1987) 273-292
40. Smith G.D., Shaw L.J., Maini P.K., et al. Mathematical modeling of ethanol metabolism in normal subjects and chronic alcohol misusers. Alcohol Alcohol 28 1 (1993) 25-32
41. Taylor P. The time course of drug action. In: Pratt W.B. (Ed). Principles of drug action. 3rd edition (1990), Churchill Livingstone, Philadelphia 297-364
42. Wasfi I.A., Al-Awadhi A.H., Al-Hatali Z.N., et al. Rapid and sensitive static headspace gas chromatography-mass spectrometry method for the analysis of ethanol and abused inhalants in blood. J Chromatogr B Analyt Technol Biomed Life Sci 799 2 (2004) 331-336
43. Macchia T., Mancinelli R., Gentili S., et al. Ethanol in biological fluids: headspace GC measurement. J Anal Toxicol 19 4 (1995) 241-246
44. Rumack B., Toll L., and Gelman C. Chloral hydrate. Micromedex healthcare series. vol. 129 (2006), Thomson Healthcare I, Micromedex Inc., Englewood (CO)
45. Breimer D.D. Clinical pharmacokinetics of hypnotics. Clin Pharmacokinet 2 2 (1977) 93-109
46. Ni Y.C., Wong T.Y., Lloyd R.V., et al. Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. Drug Metab Dispos 24 1 (1996) 81-90
47. Miyaguchi H., Kuwayama K., Tsujikawa K., et al. A method for screening for various sedative-hypnotics in serum by liquid chromatography/single quadrupole mass spectrometry. Forensic Sci Int 157 1 (2006) 57-70
48. Schmitt T.C. Determination of chloral hydrate and its metabolites in blood plasma by capillary gas chromatography with electron capture detection. J Chromatogr B Analyt Technol Biomed Life Sci 780 2 (2002) 217-224
49. Humbert L., Jacquemont M.C., Leroy E., et al. Determination of chloral hydrate and its metabolites (trichloroethanol and trichloroacetic acid) in human plasma and urine using electron capture gas chromatography. Biomed Chromatogr 8 6 (1994) 273-277
50. Roset P.N., Farre M., de la Torre R., et al. Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend 64 3 (2001) 285-298
51. Saum C.A., and Inciardi J.A. Rohypnol misuse in the United States. Subst Use Misuse 32 6 (1997) 723-731
52. Ohshima T. A case of drug-facilitated sexual assault by the use of flunitrazepam. J Clin Forensic Med 13 1 (2006) 44-45
53. Joynt B.P. Triazolam blood concentrations in forensic cases in Canada. J Anal Toxicol 17 3 (1993) 171-177
54. Cheze M., Duffort G., Deveaux M., et al. Hair analysis by liquid chromatography-tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: report of 128 cases over the period June 2003-May 2004 in metropolitan Paris. Forensic Sci Int 153 1 (2005) 3-10
55. Waltzman M.L. Flunitrazepam: a review of "roofies". Pediatr Emerg Care 15 1 (1999) 59-60
56. Mattila M.A., and Larni H.M. Flunitrazepam: a review of its pharmacological properties and therapeutic use. Drugs 20 5 (1980) 353-374
57. Chiu T.H., and Rosenberg H.C. Comparison of the kinetics of [3H]diazepam and [3H]flunitrazepam binding to cortical synaptosomal membranes. J Neurochem 39 6 (1982) 1716-1725
58. Mattila M.A., Saila K., Kokko T., et al. Comparison of diazepam and flunitrazepam as adjuncts to general anaesthesia in preventing arousal following surgical stimuli. Br J Anaesth 51 4 (1979) 329-337
59. Seppala T., Nuotto E., and Dreyfus J.F. Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam. Pharmacology 27 Suppl 2 (1983) 127-135
60. Drummer O.H., Syrjanen M.L., and Cordner S.M. Deaths involving the benzodiazepine flunitrazepam. Am J Forensic Med Pathol 14 3 (1993) 238-243
61. Kintz P., Villain M., Dumestre-Toulet V., et al. Drug-facilitated sexual assault and analytical toxicology: the role of LC-MS/MS A case involving zolpidem. J Clin Forensic Med 12 1 (2005) 36-41
62. Mastrovitch T.A., Bithoney W.G., DeBari V.A., et al. Point-of-care testing for drugs of abuse in an urban emergency department. Ann Clin Lab Sci 32 4 (2002) 383-386
63. Wu Y.H., Tan J.Y., and Xia Y. [Determination of 7-aminoflunitrazepam, the major metabolite of flunitrazepam in urine by high performance thin-layer chromatography]. Se Pu 20 2 (2002) 182-184 [in Chinese]
64. elSohly M.A., Feng S., Salamone S.J., et al. A sensitive GC-MS procedure for the analysis of flunitrazepam and its metabolites in urine. J Anal Toxicol 21 5 (1997) 335-340
65. Wang P.H., Liu C., Tsay W.I., et al. Improved screen and confirmation test of 7-aminoflunitrazepam in urine specimens for monitoring flunitrazepam (Rohypnol) exposure. J Anal Toxicol 26 7 (2002) 411-418
66. Wagner J., Wagner M.L., and Hening W.A. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 32 6 (1998) 680-691
67. Sanna E., Busonero F., Talani G., et al. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol 451 2 (2002) 103-110
68. Anonymous. Product Information: Lunesta(TM), eszopiclone (2005), Sepracor, Marlborough (MA)
69. Anderson I.B., Kim S.Y., Dyer J.E., et al. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Ann Emerg Med 47 2 (2006) 177-183
70. Goulle J.P., Cheze M., and Pepin G. Determination of endogenous levels of GHB in human hair. Are there possibilities for the identification of GHB administration through hair analysis in cases of drug-facilitated sexual assault?. J Anal Toxicol 27 8 (2003) 574-580
71. Juhascik M., Le N.L., Tomlinson K., et al. Development of an analytical approach to the specimens collected from victims of sexual assault. J Anal Toxicol 28 6 (2004) 400-406
72. Anonymous. Product Information: Ambien CR(TM), zolpidem tartrate extended-release tablets (2005), Sanofi-Synthelabo Inc., New York
73. Gock S.B., Wong S.H., Nuwayhid N., et al. Acute zolpidem overdose-report of two cases. J Anal Toxicol 23 6 (1999) 559-562
74. George C.F. Pyrazolopyrimidines. Lancet 358 9293 (2001) 1623-1626
75. Anonymous. Product Information: Lunesta(TM), eszopiclone tablets (2004), Sepracor Inc., Marlborough (MA)
76. Elliott S.P., and Burgess V. Clinical urinalysis of drugs and alcohol in instances of suspected surreptitious administration ("spiked drinks"). Sci Justice 45 3 (2005) 129-134
77. Smith K.M. Drugs used in acquaintance rape. J Am Pharm Assoc (Wash) 39 4 (1999) 519-525 [quiz: 581-3]
78. Dorandeu A.H., Pages C.A., Sordino M.C., et al. A case in south-eastern France: a review of drug facilitated sexual assault in European and English-speaking countries. J Clin Forensic Med 13 5 (2006) 253-261
79. Vayer P., Mandel P., and Maitre M. Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro. J Neurochem 45 3 (1985) 810-814
80. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51 3 (1997) 337-361
81. Drasbek K.R., Christensen J., and Jensen K. Gamma-hydroxybutyrate-a drug of abuse. Acta Neurol Scand 114 3 (2006) 145-156
82. Koek W., Carter L.P., Lamb R.J., et al. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam. J Pharmacol Exp Ther 314 1 (2005) 170-179
83. Kaupmann K., Cryan J.F., Wellendorph P., et al. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18 10 (2003) 2722-2730
84. Wu Y., Ali S., Ahmadian G., et al. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence. Neuropharmacology 47 8 (2004) 1146-1156
85. Cook C.D., Biddlestone L., Coop A., et al. Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice. Psychopharmacology (Berl) 185 1 (2006) 112-122
86. Marwick C. Coma-inducing drug GHB may be reclassified. JAMA 277 19 (1997) 1505-1506
87. Viera A.J., and Yates S.W. Toxic ingestion of gamma-hydroxybutyric acid. South Med J 92 4 (1999) 404-405
88. McCusker R.R., Paget-Wilkes H., Chronister C.W., et al. Analysis of gamma-hydroxybutyrate (GHB) in urine by gas chromatography-mass spectrometry. J Anal Toxicol 23 5 (1999) 301-305
89. Yeatman D.T., and Reid K. A study of urinary endogenous gamma-hydroxybutyrate (GHB) levels. J Anal Toxicol 27 1 (2003) 40-42
90. Green S.M., and Johnson N.E. Ketamine sedation for pediatric procedures: Part 2, Review and implications. Ann Emerg Med 19 9 (1990) 1033-1046
91. Hersack R.A. Ketamine's psychological effects do not contraindicate its use based on a patient's occupation. Aviat Space Environ Med 65 11 (1994) 1041-1046
92. Louon A., Lithander J., Reddy V.G., et al. Sedation with nasal ketamine and midazolam for cryotherapy in retinopathy of prematurity. Br J Ophthalmol 77 8 (1993) 529-530
93. Clements J.A., Nimmo W.S., et al. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 71 5 (1982) 539-542
94. Moore K.A., Sklerov J., Levine B., et al. Urine concentrations of ketamine and norketamine following illegal consumption. J Anal Toxicol 25 7 (2001) 583-588
95. Anonymous. An overview of club drugs: drug intelligence brief (2000), DEA. http://www.drugwatch.org/research/gbighb.htm Available at:
96. Macdonald R.L., and McLean M.J. Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 23 Suppl 1 (1982) S7-S18
97. Hobbs W.R., Rall T.W., and Verdoorn T.A. Hypnotics and sedatives: ethanol. In: Harman J.G., and Limbird L.E. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics. 9th edition (2002), McGraw-Hill, New York 361-396
98. Frison G., Favretto D., Tedeschi L., et al. Detection of thiopental and pentobarbital in head and pubic hair in a case of drug-facilitated sexual assault. Forensic Sci Int 133 1-2 (2003) 171-174
99. Schwenzer K.S., Pearlman R., Tsilimidos M., et al. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics. J Anal Toxicol 24 8 (2000) 726-732
100. Kupfer A., Schmid B., and Pfaff G. Pharmacogenetics of dextromethorphan O-demethylation in man. Xenobiotica 16 5 (1986) 421-433
101. Motassim N., Decolin D., Le Dinh T., et al. Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using a precolumn switching system for sample clean-up. J Chromatogr 422 (1987) 340-345
102. Palmer G.C. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr Drug Targets 2 3 (2001) 241-271
103. Price D.D., Mao J., Frenk H., et al. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 59 2 (1994) 165-174
104. Hughes A.M., Rhodes J., Fisher G., et al. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers. Br J Clin Pharmacol 53 6 (2002) 604-612
105. Ilkjaer S., Bach L.F., Nielsen P.A., et al. Effect of preoperative oral dextromethorphan on immediate and late postoperative pain and hyperalgesia after total abdominal hysterectomy. Pain 86 1-2 (2000) 19-24
106. Sindrup S.H., and Jensen T.S. Pharmacologic treatment of pain in polyneuropathy. Neurology 55 7 (2000) 915-920
107. Schwartz R.H. Adolescent abuse of dextromethorphan. Clin Pediatr (Phila) 44 7 (2005) 565-568
108. Hanzlick R. National Association of Medical Examiners Pediatric Toxicology (PedTox) Registry Report 3. Case submission summary and data for acetaminophen, benzene, carboxyhemoglobin, dextromethorphan, ethanol, phenobarbital, and pseudoephedrine. Am J Forensic Med Pathol 16 4 (1995) 270-277
109. Carlsson K.C., Hoem N.O., Moberg E.R., et al. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand 48 3 (2004) 328-336
110. Navarro A., Perry C., and Bobo W.V. A case of serotonin syndrome precipitated by abuse of the anticough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium. Gen Hosp Psychiatry 28 1 (2006) 78-80
111. *56 allele identified by genotype/phenotype analysis of cryopreserved human hepatocytes. Drug Metab Dispos 34 8 (2006) 1411-1416
112. Chen S.Q., Cai W.M., and Wedlund P.J. [Distinguishing CYP2D6 homozygous and heterozygous extensive metabolizers by dextromethorphan phenotyping]. Yao Xue Xue Bao 32 12 (1997) 924-927
113. Manaboriboon B., and Chomchai C. Dextromethorphan abuse in Thai adolescents: a report of two cases and review of literature. J Med Assoc Thai 88 Suppl 8 (2005) S242-S245
114. Anonymous. Recommended maximum detection limits for common DFSA drugs and metabolites in urine samples (2005), Drug Facilitated Sexual Assault Committee - Society of Forensic Toxicologists, Mesa (AZ) p. 1-4
115. Tomassoni A.J., and Weisman R.S. Antihistamines and decongestants. In: Flomenbaum N.E., Goldfrank L.R., Hoffman R.S., et al. (Eds). Goldfrank's toxicologic emergencies. 8th edition (2005), McGraw-Hill, New York 785-793
116. Albert K.S., Hallmark M.R., Sakmar E., et al. Pharmacokinetics of diphenhydramine in man. J Pharmacokinet Biopharm 3 3 (1975) 159-170
117. Sharma A.N., Hexdall A.H., Chang E.K., et al. Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate. Am J Emerg Med 21 3 (2003) 212-215
118. Hasegawa C., Kumazawa T., Lee X.P., et al. Simultaneous determination of ten antihistamine drugs in human plasma using pipette tip solid-phase extraction and gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20 4 (2006) 537-543